Condition: Alternative Surgical Treatment for Aortic Valve Disease · Sponsor: Deutsches Herzzentrum Muenchen
Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a biological prosthesis (St. Jude Trifecta GT) as gold- standard.
This description comes directly from the study's public registry record.
Markus Krane, MD, PhD · +4989-1218 · krane@dhm.mhn.de
Always discuss trial participation with your own doctor first.
| Department of Cardiovascular Surgery, German Heart Center Munich | Munich, Bavaria, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03600662